Global imaging CRO Leverage IAG’s global footprint across the UK, EU, US, and APAC to position integrated imaging solutions for multi-region clinical trials, enabling sponsors to streamline regulatory submissions and centralized imaging workflows.

Integrated cardiac safety Capitalise on the May 2026 strategic partnership with HeartcoR Solutions to offer fully integrated cardiac safety monitoring and imaging services, expanding the reach into cardiology-focused trials and improving safety data quality.

AI driven analytics Highlight the DYNAMIKA platform and recent V7 release to clients as a differentiator for automated, quantitative imaging biomarkers and rapid readouts, enabling faster trial decision-making and scalable analysis across modalities.

Regulatory readiness Emphasise IAG’s end-to-end regulatory support for IND, NDA/BLA, MAA submissions and compliance with ICH-GCP, 21 CFR Part 11, GDPR, HIPAA, ISO standards to attract sponsors seeking compliant, audit-ready imaging data for submissions.

Clinical trial breadth Position IAG as a one-stop imaging partner with expertise across oncology, rheumatology, orthopedics, obesity, cardiology, hepatology, neurology, and rare diseases, appealing to sponsors running diverse Phase I–IV trials and needing multiple imaging endpoints and scoring systems.